跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MIRTAZAPINA TEVA-RATIO 15 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
MIRTAZAPINA TEVA-RATIO 15 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
MIRTAZAPINA TEVA-RATIO 15 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Teva B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 31, 2023
Approval ID
8925109043c399b9
Company
Teva B.V.
Type
Standard
Approval Details
Approval Id
8925109043c399b9
Drug Cima Aemps Name
MIRTAZAPINA TEVA-RATIO 15 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
88858
Holder Company Name
Teva B.V.
Marketing Company Name
Teva Pharma S.L.U.
Holder Company Detail Path
/organization/teva-pharma-b-v
Authorization Date
2023-07-31
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
15 MG
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Teva B.V.
Company Detail Path
/organization/teva-pharma-b-v
Company Information
Pharmaceutical Company Name
Teva Pharma B.V.
Country Name
Netherlands
City Name
haarlem,noord-holland,country_nl
Address
Swensweg 5
Website
http://www.tevapharm.com
Active Ingredients
MIRTAZAPINA
15 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 31, 2023
Approval ID
8925109043c399b9
Type
Standard
Back to CIMA-AEMPS Approvals